Prospective Evaluation of <i>MGMT</i>-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors.
作者:
主题词
人类(Humans);抗肿瘤药, 烷基化(Antineoplastic Agents, Alkylating);神经内分泌瘤(Neuroendocrine Tumors);前瞻性研究(Prospective Studies);甲基化(Methylation);DNA修饰甲基酶类(DNA Modification Methylases);肿瘤抑制蛋白质类(Tumor Suppressor Proteins);DNA修复酶类(DNA Repair Enzymes)
DOI
10.3390/curroncol30020106
PMID
36826067
发布时间
2023-03-21
- 浏览0

Current oncology (Toronto, Ont.)
1381-1394页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文